scholarly journals Background and Rationale (Part 1 of Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-onset Type 1 Diabetes Mellitus) v1 (protocols.io.bu8knzuw)

protocols.io ◽  
2021 ◽  
Author(s):  
Stephen.Gitelman not provided ◽  
Jeffrey A.
Sign in / Sign up

Export Citation Format

Share Document